Vesicular and bullous eczema in response to intravenous immunoglobulins (IVIG).
Maetzke
J
J
Department of Dermatology, University of Ulm, Maienweg 12, 89081 Ulm, Germany.
Sperfeld
A-D
AD
Scharffetter-Kochanek
K
K
Sunderkötter
C
C
D000328:Adult; D004305:Dose-Response Relationship, Drug; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000503:physiopathology; D005500:Follow-Up Studies; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D009468:Neuromuscular Diseases / Q000175:diagnosis / Q000188:drug therapy; D018570:Risk Assessment; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000503:physiopathology
D016756:Immunoglobulins, Intravenous